WSJ 专栏：Moderna 癌症疫苗通过首次重大考验，但股价定价已透支成功
Heard on the Street: Moderna’s cancer vaccine passed its first big test this past week. The bigger problem is that its stock is priced as if it has a...
AI 导读
WSJ「Heard on the Street」专栏称 Moderna 的癌症疫苗在过去一周通过了首次重大考验。专栏认为更大的问题在于其股票定价仿佛已通过所有考验，即估值已提前计入了全部成功。